BBIO
BridgeBio Pharma, Inc.Healthcare$73.15
▲ Bullish
Mkt Cap: $14.18B|Float: 159.6M|SI: 14.7%|DTC: 7.8
Data as of market close Apr 2, 2026
IV Rank
36
IV Pctl
33%
HV 20d
61.2%
52W Range
$28-$85
ATR(14)
$2.94
Exp. Move
±8.9%
P/C Ratio
0.84
Earnings
Apr 28
GEX Positive
DEX Long
Net Call Premium
IV Moderate
Max Pain Below
Exp. Move Wide
BBIO Key Options Data
- IV Rank
- 36.3%
- Total GEX
- $0.00B
- Total DEX
- $1.4M
- Max Pain
- $65.00
- Expected Move
- ±8.9%
- Put/Call OI
- 0.84
- Net Premium
- $1.5M
- Spot Price
- $73.15
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$6.55 | ±8.9% | $66.60 | $79.70 |
| 2026-05-15 | 43 | ±$11.70 | ±16.0% | $61.45 | $84.85 |
| 2026-07-17 | 106 | ±$18.90 | ±25.8% | $54.25 | $92.05 |
| 2026-08-21 | 141 | ±$10.80 | ±14.8% | $62.35 | $83.95 |
| 2027-01-15 | 288 | ±$30.80 | ±42.1% | $42.35 | $103.95 |
| 2027-02-19 | 323 | ±$14.65 | ±20.0% | $58.50 | $87.80 |
Explore BBIO options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.